
Daiichi Life's Revised Bid for Challenger Rejected Again
Daiichi Life's Australian arm, TAL Daiichi Life Australia, raised its takeover offer for Challenger to A$12.20 a share for the 79.5% stake it doesn't already own. That is up from the A$11.80 per share Challenger's board turned down in October. The board rejected this revised bid too, saying it still does not represent fair value in a control transaction for Challenger ($CGF) shareholders. Daiichi Life has now been rebuffed twice in a month while holding nearly a fifth of the company already.